US Stock MarketDetailed Quotes

RUBY Rubius Therapeutics

Watchlist
  • 0.057000
  • 0.0000000.00%
15min DelayTrading Dec 29 16:00 ET
5.16MMarket Cap-28P/E (TTM)

Rubius Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-3.46%-150.14M
12.63%-32.52M
-5.10%-36.2M
1.25%-34.29M
-21.67%-47.14M
-13.69%-145.12M
-21.83%-37.22M
-20.72%-34.45M
-21.60%-34.72M
3.19%-38.74M
Net income from continuing operations
8.59%-179.67M
63.40%-20.14M
-28.27%-62.87M
11.84%-44.24M
-23.82%-52.41M
-17.18%-196.55M
-35.72%-55.02M
-19.98%-49.02M
-32.56%-50.18M
12.70%-42.33M
Operating gains losses
---1.13M
----
----
----
----
----
----
----
----
----
Depreciation and amortization
-19.02%6.25M
-87.41%427K
102.35%2.67M
5.47%1.6M
4.21%1.56M
35.71%7.72M
558.64%3.39M
-18.13%1.32M
-14.64%1.52M
-16.38%1.5M
Other non cash items
-52.81%604K
-106.97%-17K
-0.87%227K
66.67%190K
-70.56%204K
266.76%1.28M
108.55%244K
163.22%229K
96.55%114K
696.55%693K
Change In working capital
-361.80%-17.53M
-468.97%-18.4M
-52.04%2.31M
-21.63%3.28M
35.34%-4.72M
5,876.79%6.69M
1,370.80%4.99M
89.44%4.83M
559.78%4.18M
-291.68%-7.3M
-Change in prepaid assets
119.22%2.74M
-35.07%1.61M
123.95%97K
270.94%747K
174.74%287K
25.91%1.25M
6.91%2.48M
-137.12%-405K
86.87%-437K
-142.01%-384K
-Change in payables and accrued expense
-425.78%-16.43M
-690.35%-15.85M
-57.85%2.11M
-46.10%2.4M
28.33%-5.08M
444.16%5.04M
336.56%2.69M
489.61%4.99M
137.45%4.45M
-132.27%-7.08M
-Change in other current assets
30.83%7M
160.37%3.11M
-6.03%1.34M
-6.01%1.3M
-7.35%1.25M
-3.38%5.35M
-11.73%1.2M
8.43%1.43M
7.21%1.38M
-14.69%1.35M
-Change in other current liabilities
-118.79%-10.84M
-428.51%-7.27M
-3.19%-1.23M
3.57%-1.16M
0.17%-1.18M
0.92%-4.95M
38.67%-1.38M
-68.46%-1.19M
-62.31%-1.21M
9.63%-1.18M
-Change in other working capital
----
----
----
----
----
-89.13%5K
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-3.46%-150.14M
12.63%-32.52M
-5.10%-36.2M
1.25%-34.29M
-21.67%-47.14M
-13.69%-145.12M
-21.83%-37.22M
-20.72%-34.45M
-21.60%-34.72M
3.19%-38.74M
Investing cash flow
Cash flow from continuing investing activities
-84.09%12.94M
1,391.23%17.68M
444.18%77.88M
-106.61%-1.76M
-293.64%-80.85M
-19.00%81.35M
-102.95%-1.37M
154.77%14.31M
321.09%26.66M
-54.69%41.75M
Net PPE purchase and sale
446.37%12.64M
1,391.23%17.68M
-26.71%-873K
-109.13%-1.76M
-221.12%-2.4M
33.62%-3.65M
-32.91%-1.37M
-32.25%-689K
23.01%-843K
73.76%-748K
Net investment purchase and sale
-99.64%305K
--0
425.00%78.75M
--0
-284.58%-78.45M
-19.76%85M
--0
158.58%15M
350.87%27.5M
-55.26%42.5M
Cash from discontinued investing activities
Investing cash flow
-84.09%12.94M
1,391.23%17.68M
444.18%77.88M
-106.61%-1.76M
-293.64%-80.85M
-19.00%81.35M
-102.95%-1.37M
154.77%14.31M
321.09%26.66M
-54.69%41.75M
Financing cash flow
Cash flow from continuing financing activities
-138.03%-75.47M
-18,297.60%-75.7M
0
-95.14%156K
-99.96%76K
649.33%198.45M
477.78%416K
37.16%919K
-87.29%3.21M
39,798.77%193.91M
Net issuance payments of debt
---75.7M
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--0
--0
--0
--0
--0
--188M
--0
--0
--0
--188M
Proceeds from stock option exercised by employees
-97.88%232K
--0
--0
-95.81%156K
-98.71%76K
638.75%10.96M
477.78%416K
37.16%919K
1,353.13%3.72M
1,115.64%5.91M
Net other financing activities
----
----
----
----
----
---510K
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-138.03%-75.47M
-18,297.60%-75.7M
--0
-95.14%156K
-99.96%76K
649.33%198.45M
477.78%416K
37.16%919K
-87.29%3.21M
39,798.77%193.91M
Net cash flow
Beginning cash position
144.97%227.58M
-60.32%105.46M
-77.62%63.78M
-65.61%99.68M
144.97%227.58M
-0.78%92.9M
245.54%265.75M
117.70%284.97M
98.17%289.82M
-0.78%92.9M
Current changes in cash
-257.90%-212.67M
-137.21%-90.54M
316.87%41.67M
-639.60%-35.89M
-164.95%-127.91M
18,499.18%134.68M
-338.68%-38.17M
64.41%-19.22M
68.39%-4.85M
274.24%196.92M
End cash Position
-93.45%14.92M
-93.45%14.92M
-60.32%105.46M
-77.62%63.78M
-65.61%99.68M
144.97%227.58M
144.97%227.58M
245.54%265.75M
117.70%284.97M
98.17%289.82M
Free cash flow
-4.49%-155.45M
15.04%-32.78M
-5.53%-37.08M
-1.37%-36.05M
-25.45%-49.54M
-11.74%-148.77M
-22.19%-38.59M
-20.93%-35.14M
-19.95%-35.56M
7.88%-39.49M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -3.46%-150.14M12.63%-32.52M-5.10%-36.2M1.25%-34.29M-21.67%-47.14M-13.69%-145.12M-21.83%-37.22M-20.72%-34.45M-21.60%-34.72M3.19%-38.74M
Net income from continuing operations 8.59%-179.67M63.40%-20.14M-28.27%-62.87M11.84%-44.24M-23.82%-52.41M-17.18%-196.55M-35.72%-55.02M-19.98%-49.02M-32.56%-50.18M12.70%-42.33M
Operating gains losses ---1.13M------------------------------------
Depreciation and amortization -19.02%6.25M-87.41%427K102.35%2.67M5.47%1.6M4.21%1.56M35.71%7.72M558.64%3.39M-18.13%1.32M-14.64%1.52M-16.38%1.5M
Other non cash items -52.81%604K-106.97%-17K-0.87%227K66.67%190K-70.56%204K266.76%1.28M108.55%244K163.22%229K96.55%114K696.55%693K
Change In working capital -361.80%-17.53M-468.97%-18.4M-52.04%2.31M-21.63%3.28M35.34%-4.72M5,876.79%6.69M1,370.80%4.99M89.44%4.83M559.78%4.18M-291.68%-7.3M
-Change in prepaid assets 119.22%2.74M-35.07%1.61M123.95%97K270.94%747K174.74%287K25.91%1.25M6.91%2.48M-137.12%-405K86.87%-437K-142.01%-384K
-Change in payables and accrued expense -425.78%-16.43M-690.35%-15.85M-57.85%2.11M-46.10%2.4M28.33%-5.08M444.16%5.04M336.56%2.69M489.61%4.99M137.45%4.45M-132.27%-7.08M
-Change in other current assets 30.83%7M160.37%3.11M-6.03%1.34M-6.01%1.3M-7.35%1.25M-3.38%5.35M-11.73%1.2M8.43%1.43M7.21%1.38M-14.69%1.35M
-Change in other current liabilities -118.79%-10.84M-428.51%-7.27M-3.19%-1.23M3.57%-1.16M0.17%-1.18M0.92%-4.95M38.67%-1.38M-68.46%-1.19M-62.31%-1.21M9.63%-1.18M
-Change in other working capital ---------------------89.13%5K----------------
Cash from discontinued investing activities
Operating cash flow -3.46%-150.14M12.63%-32.52M-5.10%-36.2M1.25%-34.29M-21.67%-47.14M-13.69%-145.12M-21.83%-37.22M-20.72%-34.45M-21.60%-34.72M3.19%-38.74M
Investing cash flow
Cash flow from continuing investing activities -84.09%12.94M1,391.23%17.68M444.18%77.88M-106.61%-1.76M-293.64%-80.85M-19.00%81.35M-102.95%-1.37M154.77%14.31M321.09%26.66M-54.69%41.75M
Net PPE purchase and sale 446.37%12.64M1,391.23%17.68M-26.71%-873K-109.13%-1.76M-221.12%-2.4M33.62%-3.65M-32.91%-1.37M-32.25%-689K23.01%-843K73.76%-748K
Net investment purchase and sale -99.64%305K--0425.00%78.75M--0-284.58%-78.45M-19.76%85M--0158.58%15M350.87%27.5M-55.26%42.5M
Cash from discontinued investing activities
Investing cash flow -84.09%12.94M1,391.23%17.68M444.18%77.88M-106.61%-1.76M-293.64%-80.85M-19.00%81.35M-102.95%-1.37M154.77%14.31M321.09%26.66M-54.69%41.75M
Financing cash flow
Cash flow from continuing financing activities -138.03%-75.47M-18,297.60%-75.7M0-95.14%156K-99.96%76K649.33%198.45M477.78%416K37.16%919K-87.29%3.21M39,798.77%193.91M
Net issuance payments of debt ---75.7M------------------0----------------
Net common stock issuance --0--0--0--0--0--188M--0--0--0--188M
Proceeds from stock option exercised by employees -97.88%232K--0--0-95.81%156K-98.71%76K638.75%10.96M477.78%416K37.16%919K1,353.13%3.72M1,115.64%5.91M
Net other financing activities -----------------------510K--0--0--------
Cash from discontinued financing activities
Financing cash flow -138.03%-75.47M-18,297.60%-75.7M--0-95.14%156K-99.96%76K649.33%198.45M477.78%416K37.16%919K-87.29%3.21M39,798.77%193.91M
Net cash flow
Beginning cash position 144.97%227.58M-60.32%105.46M-77.62%63.78M-65.61%99.68M144.97%227.58M-0.78%92.9M245.54%265.75M117.70%284.97M98.17%289.82M-0.78%92.9M
Current changes in cash -257.90%-212.67M-137.21%-90.54M316.87%41.67M-639.60%-35.89M-164.95%-127.91M18,499.18%134.68M-338.68%-38.17M64.41%-19.22M68.39%-4.85M274.24%196.92M
End cash Position -93.45%14.92M-93.45%14.92M-60.32%105.46M-77.62%63.78M-65.61%99.68M144.97%227.58M144.97%227.58M245.54%265.75M117.70%284.97M98.17%289.82M
Free cash flow -4.49%-155.45M15.04%-32.78M-5.53%-37.08M-1.37%-36.05M-25.45%-49.54M-11.74%-148.77M-22.19%-38.59M-20.93%-35.14M-19.95%-35.56M7.88%-39.49M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg